Among the many implications of November’s presidential election, there are few more impactful than those for the healthcare sector

The energy world is receiving an expanded examination from Mizuho with additional energy research coverage in recent months

The term “new normal,” coined by Mohamed El-Erian during his PIMCO days, has sparked a debate among economists and market participants which continues to rage without consensus

We recently surveyed investors and corporates on drug pricing and reimbursement at our 2016 Global Mizuho Investors Conference in New York. Here are the results

Last year, more than 38 million Americans traveled during the holiday season, according to AAA – that's about one-tenth of the entire U.S. population!

We believe that AMZN, EBAY, GOOGL should benefit from the strong start in eCommerce sales from Thanksgiving

When the right answer to the question, "What will happen to the ACA, Medicaid and Medicare?' is we don't and can't know, we see it as dangerous ground for investing

Mizuho's Healthcare Team has collaborated to update our January work showing that healthcare outperforms post-election when gridlock reigns, and give our joint view of the best ways to play the possible outcomes

Despite its size and importance for corporates, the commercial paper markets are typically a low profile corner of the capital markets and rarely get much press